Schroder Investment Management Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.2M Sell
3,722,873
-587,332
-14% -$4.29M 0.02% 448
2025
Q1
$41.5M Buy
4,310,205
+509,990
+13% +$4.91M 0.04% 327
2024
Q4
$62.6M Sell
3,800,215
-419,612
-10% -$6.92M 0.06% 254
2024
Q3
$61.2M Buy
4,219,827
+21,195
+0.5% +$307K 0.06% 250
2024
Q2
$58.2M Buy
4,198,632
+1,094,529
+35% +$15.2M 0.06% 248
2024
Q1
$48.8M Buy
3,104,103
+623,679
+25% +$9.8M 0.06% 292
2023
Q4
$40.1M Sell
2,480,424
-32,883
-1% -$532K 0.05% 331
2023
Q3
$30.9M Buy
2,513,307
+529,178
+27% +$6.51M 0.05% 352
2023
Q2
$31.9M Sell
1,984,129
-348,305
-15% -$5.6M 0.05% 378
2023
Q1
$40.6M Buy
2,332,434
+30,047
+1% +$523K 0.06% 321
2022
Q4
$21.3M Buy
2,302,387
+574,815
+33% +$5.31M 0.03% 441
2022
Q3
$14.9M Sell
1,727,572
-568,111
-25% -$4.89M 0.02% 517
2022
Q2
$18.7M Sell
2,295,683
-103,555
-4% -$844K 0.03% 483
2022
Q1
$29.2M Buy
2,399,238
+553,019
+30% +$6.72M 0.04% 406
2021
Q4
$63M Buy
1,846,219
+838,228
+83% +$28.6M 0.08% 247
2021
Q3
$48.6M Buy
+1,007,991
New +$48.6M 0.07% 271